Full coverageGLP-1 Drugs Double Risk of Neovascular Age-Related Macular Degeneration in Diabetic Patients
By Mark Chiang
Top news
Popular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim
By Anthony G. Attrino
Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court
By Irvin Jackson
GLP-1 Receptor Agonists Could Reduce Risk of Glaucoma in Type 2 Diabetes
By Julia Bonavitacola
All coverage
Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests
By Shiv Sudhakar
A link between some weight loss drugs and potentially blinding eye disease — and more
By Katharin Czink, Lourdes Duarte and Ben Bradley
GLP-1 Receptor Agonists Linked to Doubled Risk of Neovascular Age-Related Macular Degeneration in Diabetic Patients
By Mark Chiang
Ozempic, Wegovy Users Want NJ To Host Vision-Loss Suits
By Carla Baranauckas